Single-arm cohort study: percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy.

Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy – JAMA Cardiology (free for a limited period)

Invited Commentary: Septal Reduction Strategies in Hypertrophic Cardiomyopathy—The Scalpel, Catheter, or Wire? – JAMA Cardiology (free for a limited period)

Video: Percutaneous Intramyocardial Septal Radiofrequency Ablation

Commentary on Twitter

In this cohort study, percutaneous intramyocardial septal radiofrequency ablation was associated with a durable reduction in peak left ventricular outflow tract gradients. Medium-term follow-up saw improvement in symptoms with low morbidity and mortality. https://t.co/DiyLHPR0Bw

— JAMA Cardiology (@JAMACardio) April 1, 2022